Efficacy of rabeprazole (Razo®) in the treatment of various clinical variants of GERD: results from the GERBERA study

Efficacy of rabeprazole (Razo®) in the treatment of various clinical variants of GERD: results from the GERBERA study

Introduction. Gastroesophageal reflux disease (GERD) is extremely common in the structure of gastroenterological diseases. Aim. To conduct a prospective observational post-marketing study of rabeprazole (Razo®) 20 mg taking once daily in patients with non-erosive reflux disease (NERD) after 2 and 4...

Full description

Bibliographic Details
Main Authors: V. V. Tsukanov, M. A. Cherepnin, A. V. Vasyutin, J. L. Tonkikh, E. V. Kasparov, N. A. Maslennikova, N. V. Pavlova
Format: Article
Language:Russian
Published: Remedium Group LLC 2022-05-01
Series:Медицинский совет
Subjects:
gerb
esophagitis
proton pump inhibitors
rabeprazole
treatment
Online Access:https://www.med-sovet.pro/jour/article/view/6857

Internet

https://www.med-sovet.pro/jour/article/view/6857

Similar Items